Overview
Karthikeyan Annamalai practices practicing medicine in Ulm, Germany.
His clinical expertise encompasses Primary Amyloidosis.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Karthikeyan Annamalai
Is Karthikeyan Annamalai a top-rated expert for Primary Amyloidosis?
MediFind is an objective health platform that identifies experts based on real-world data. Karthikeyan Annamalai is classified as an Experienced expert for Primary Amyloidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Karthikeyan Annamalai participate in research or clinical trials?
Yes. Karthikeyan Annamalai has published 9 articles and abstracts on conditions like Primary Amyloidosis. You can view a list of Karthikeyan Annamalai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers